Comerica Bank Acquires 4,472 Shares of Smith & Nephew plc (SNN)

Comerica Bank lifted its holdings in Smith & Nephew plc (NYSE:SNN) by 15.3% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 33,674 shares of the medical equipment provider’s stock after buying an additional 4,472 shares during the quarter. Comerica Bank’s holdings in Smith & Nephew were worth $1,134,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of the company. Alps Advisors Inc. boosted its holdings in shares of Smith & Nephew by 73.3% during the third quarter. Alps Advisors Inc. now owns 13,946 shares of the medical equipment provider’s stock worth $517,000 after purchasing an additional 5,900 shares during the period. Avestar Capital LLC boosted its holdings in shares of Smith & Nephew by 25.8% during the third quarter. Avestar Capital LLC now owns 7,910 shares of the medical equipment provider’s stock worth $276,000 after purchasing an additional 1,623 shares during the period. Northern Trust Corp boosted its holdings in shares of Smith & Nephew by 1.0% during the second quarter. Northern Trust Corp now owns 689,297 shares of the medical equipment provider’s stock worth $25,870,000 after purchasing an additional 6,530 shares during the period. Glenmede Trust Co. NA boosted its holdings in shares of Smith & Nephew by 22.4% during the second quarter. Glenmede Trust Co. NA now owns 981,568 shares of the medical equipment provider’s stock worth $36,838,000 after purchasing an additional 179,800 shares during the period. Finally, Capital Fund Management S.A. acquired a new stake in shares of Smith & Nephew during the second quarter worth approximately $210,000. Institutional investors own 9.03% of the company’s stock.

NYSE SNN opened at $37.93 on Friday. The company has a quick ratio of 1.05, a current ratio of 2.13 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $16.23 billion, a price-to-earnings ratio of 19.96, a price-to-earnings-growth ratio of 3.01 and a beta of 0.60. Smith & Nephew plc has a 12-month low of $32.22 and a 12-month high of $39.85.

A number of analysts have issued reports on the stock. Zacks Investment Research upgraded shares of Smith & Nephew from a “sell” rating to a “hold” rating in a research note on Friday, November 2nd. Deutsche Bank upgraded shares of Smith & Nephew from a “sell” rating to a “hold” rating in a research note on Friday. Canaccord Genuity reiterated a “buy” rating on shares of Smith & Nephew in a research note on Thursday, November 1st. Finally, HSBC cut shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Tuesday, October 16th. Five analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Smith & Nephew currently has an average rating of “Hold” and a consensus price target of $42.00.

COPYRIGHT VIOLATION WARNING: This piece of content was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2018/12/08/comerica-bank-acquires-4472-shares-of-smith-nephew-plc-snn.html.

About Smith & Nephew

Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

Read More: Conference Calls

Institutional Ownership by Quarter for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply